Global Influenza Drugs and Vaccines Market Research Report 2021

Global Influenza Drugs and Vaccines Market Research Report 2021

Table of Contents
1 Influenza Drugs and Vaccines Market Overview
1.1 Product Overview and Scope of Influenza Drugs and Vaccines
1.2 Influenza Drugs and Vaccines Segment by Type
1.2.1 Global Influenza Drugs and Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Influenza Drugs
1.2.3 Influenza Vaccines
1.3 Influenza Drugs and Vaccines Segment by Application
1.3.1 Influenza Drugs and Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Influenza Drugs and Vaccines Market Size Estimates and Forecasts
1.4.1 Global Influenza Drugs and Vaccines Revenue 2016-2027
1.4.2 Global Influenza Drugs and Vaccines Sales 2016-2027
1.4.3 Influenza Drugs and Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Influenza Drugs and Vaccines Market Competition by Manufacturers
2.1 Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Influenza Drugs and Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Influenza Drugs and Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Influenza Drugs and Vaccines Market Competitive Situation and Trends
2.5.1 Influenza Drugs and Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Influenza Drugs and Vaccines Players Market Share by Revenue
2.5.3 Global Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Drugs and Vaccines Retrospective Market Scenario by Region
3.1 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Influenza Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Influenza Drugs and Vaccines Market Facts & Figures by Country
3.3.1 North America Influenza Drugs and Vaccines Sales by Country
3.3.2 North America Influenza Drugs and Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country
3.4.1 Europe Influenza Drugs and Vaccines Sales by Country
3.4.2 Europe Influenza Drugs and Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Influenza Drugs and Vaccines Sales by Region
3.5.2 Asia Pacific Influenza Drugs and Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Influenza Drugs and Vaccines Market Facts & Figures by Country
3.6.1 Latin America Influenza Drugs and Vaccines Sales by Country
3.6.2 Latin America Influenza Drugs and Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Influenza Drugs and Vaccines Sales by Country
3.7.2 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Influenza Drugs and Vaccines Historic Market Analysis by Type
4.1 Global Influenza Drugs and Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Influenza Drugs and Vaccines Price by Type (2016-2021)
5 Global Influenza Drugs and Vaccines Historic Market Analysis by Application
5.1 Global Influenza Drugs and Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Influenza Drugs and Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bristol Myers Squibb Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 AstraZeneca Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eli Lilly Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 GlaxoSmithKline Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Sanofi Pasteur
6.8.1 Sanofi Pasteur Corporation Information
6.8.2 Sanofi Pasteur Description and Business Overview
6.8.3 Sanofi Pasteur Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Pasteur Product Portfolio
6.8.5 Sanofi Pasteur Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bayer Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Celgene
6.10.1 Celgene Corporation Information
6.10.2 Celgene Description and Business Overview
6.10.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Celgene Product Portfolio
6.10.5 Celgene Recent Developments/Updates
6.11 Seqirus
6.11.1 Seqirus Corporation Information
6.11.2 Seqirus Influenza Drugs and Vaccines Description and Business Overview
6.11.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Seqirus Product Portfolio
6.11.5 Seqirus Recent Developments/Updates
6.12 Protein Sciences Corporation
6.12.1 Protein Sciences Corporation Corporation Information
6.12.2 Protein Sciences Corporation Influenza Drugs and Vaccines Description and Business Overview
6.12.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Protein Sciences Corporation Product Portfolio
6.12.5 Protein Sciences Corporation Recent Developments/Updates
6.13 Serum Institute of India
6.13.1 Serum Institute of India Corporation Information
6.13.2 Serum Institute of India Influenza Drugs and Vaccines Description and Business Overview
6.13.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Serum Institute of India Product Portfolio
6.13.5 Serum Institute of India Recent Developments/Updates
6.14 Emergent Biosolutions
6.14.1 Emergent Biosolutions Corporation Information
6.14.2 Emergent Biosolutions Influenza Drugs and Vaccines Description and Business Overview
6.14.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Emergent Biosolutions Product Portfolio
6.14.5 Emergent Biosolutions Recent Developments/Updates
6.15 BioCryst Pharmaceuticals
6.15.1 BioCryst Pharmaceuticals Corporation Information
6.15.2 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Description and Business Overview
6.15.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 BioCryst Pharmaceuticals Product Portfolio
6.15.5 BioCryst Pharmaceuticals Recent Developments/Updates
6.16 Alvogen
6.16.1 Alvogen Corporation Information
6.16.2 Alvogen Influenza Drugs and Vaccines Description and Business Overview
6.16.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Alvogen Product Portfolio
6.16.5 Alvogen Recent Developments/Updates
7 Influenza Drugs and Vaccines Manufacturing Cost Analysis
7.1 Influenza Drugs and Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Influenza Drugs and Vaccines
7.4 Influenza Drugs and Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Influenza Drugs and Vaccines Distributors List
8.3 Influenza Drugs and Vaccines Customers
9 Influenza Drugs and Vaccines Market Dynamics
9.1 Influenza Drugs and Vaccines Industry Trends
9.2 Influenza Drugs and Vaccines Growth Drivers
9.3 Influenza Drugs and Vaccines Market Challenges
9.4 Influenza Drugs and Vaccines Market Restraints
10 Global Market Forecast
10.1 Influenza Drugs and Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Influenza Drugs and Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Influenza Drugs and Vaccines by Type (2022-2027)
10.2 Influenza Drugs and Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Influenza Drugs and Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Influenza Drugs and Vaccines by Application (2022-2027)
10.3 Influenza Drugs and Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Influenza Drugs and Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Influenza Drugs and Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Influenza Drugs and Vaccines Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Influenza Drugs and Vaccines Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Influenza Drugs and Vaccines Covered in This Study
Table 5. Global Influenza Drugs and Vaccines Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Influenza Drugs and Vaccines Sales Share by Manufacturers (2016-2021)
Table 7. Global Influenza Drugs and Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Influenza Drugs and Vaccines Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Influenza Drugs and Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Influenza Drugs and Vaccines Product Type
Table 12. Global Influenza Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Influenza Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs and Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Influenza Drugs and Vaccines Sales by Region (2016-2021) & (MT)
Table 16. Global Influenza Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Influenza Drugs and Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 19. North America Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 23. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Influenza Drugs and Vaccines Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Influenza Drugs and Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 31. Latin America Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Influenza Drugs and Vaccines Sales (MT) by Type (2016-2021)
Table 39. Global Influenza Drugs and Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Influenza Drugs and Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Influenza Drugs and Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Influenza Drugs and Vaccines Price (USD/Kg) by Type (2016-2021)
Table 43. Global Influenza Drugs and Vaccines Sales (MT) by Application (2016-2021)
Table 44. Global Influenza Drugs and Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Influenza Drugs and Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Influenza Drugs and Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Influenza Drugs and Vaccines Price (USD/Kg) by Application (2016-2021)
Table 48. Bristol Myers Squibb Corporation Information
Table 49. Bristol Myers Squibb Description and Business Overview
Table 50. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Bristol Myers Squibb Influenza Drugs and Vaccines Product
Table 52. Bristol Myers Squibb Recent Developments/Updates
Table 53. AstraZeneca Corporation Information
Table 54. AstraZeneca Description and Business Overview
Table 55. AstraZeneca Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. AstraZeneca Influenza Drugs and Vaccines Product
Table 57. AstraZeneca Recent Developments/Updates
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Business Overview
Table 60. Eli Lilly Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Eli Lilly Influenza Drugs and Vaccines Product
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Roche Corporation Information
Table 64. Roche Description and Business Overview
Table 65. Roche Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Roche Influenza Drugs and Vaccines Product
Table 67. Roche Recent Developments/Updates
Table 68. GlaxoSmithKline Corporation Information
Table 69. GlaxoSmithKline Description and Business Overview
Table 70. GlaxoSmithKline Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. GlaxoSmithKline Influenza Drugs and Vaccines Product
Table 72. GlaxoSmithKline Recent Developments/Updates
Table 73. Novartis Corporation Information
Table 74. Novartis Description and Business Overview
Table 75. Novartis Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Novartis Influenza Drugs and Vaccines Product
Table 77. Novartis Recent Developments/Updates
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Pfizer Influenza Drugs and Vaccines Product
Table 82. Pfizer Recent Developments/Updates
Table 83. Sanofi Pasteur Corporation Information
Table 84. Sanofi Pasteur Description and Business Overview
Table 85. Sanofi Pasteur Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Sanofi Pasteur Influenza Drugs and Vaccines Product
Table 87. Sanofi Pasteur Recent Developments/Updates
Table 88. Bayer Corporation Information
Table 89. Bayer Description and Business Overview
Table 90. Bayer Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Bayer Influenza Drugs and Vaccines Product
Table 92. Bayer Recent Developments/Updates
Table 93. Celgene Corporation Information
Table 94. Celgene Description and Business Overview
Table 95. Celgene Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Celgene Influenza Drugs and Vaccines Product
Table 97. Celgene Recent Developments/Updates
Table 98. Seqirus Corporation Information
Table 99. Seqirus Description and Business Overview
Table 100. Seqirus Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. Seqirus Influenza Drugs and Vaccines Product
Table 102. Seqirus Recent Developments/Updates
Table 103. Protein Sciences Corporation Corporation Information
Table 104. Protein Sciences Corporation Description and Business Overview
Table 105. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Protein Sciences Corporation Influenza Drugs and Vaccines Product
Table 107. Protein Sciences Corporation Recent Developments/Updates
Table 108. Serum Institute of India Corporation Information
Table 109. Serum Institute of India Description and Business Overview
Table 110. Serum Institute of India Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. Serum Institute of India Influenza Drugs and Vaccines Product
Table 112. Serum Institute of India Recent Developments/Updates
Table 113. Emergent Biosolutions Corporation Information
Table 114. Emergent Biosolutions Description and Business Overview
Table 115. Emergent Biosolutions Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Emergent Biosolutions Influenza Drugs and Vaccines Product
Table 117. Emergent Biosolutions Recent Developments/Updates
Table 118. BioCryst Pharmaceuticals Corporation Information
Table 119. BioCryst Pharmaceuticals Description and Business Overview
Table 120. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product
Table 122. BioCryst Pharmaceuticals Recent Developments/Updates
Table 123. Alvogen Corporation Information
Table 124. Alvogen Description and Business Overview
Table 125. Alvogen Influenza Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. Alvogen Influenza Drugs and Vaccines Product
Table 127. Alvogen Recent Developments/Updates
Table 128. Production Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Influenza Drugs and Vaccines Distributors List
Table 131. Influenza Drugs and Vaccines Customers List
Table 132. Influenza Drugs and Vaccines Market Trends
Table 133. Influenza Drugs and Vaccines Growth Drivers
Table 134. Influenza Drugs and Vaccines Market Restraints
Table 135. Global Influenza Drugs and Vaccines Sales Forecast by Type (2022-2027) & (MT)
Table 136. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 137. Global Influenza Drugs and Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 138. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 139. Global Influenza Drugs and Vaccines Sales Forecast by Application (2022-2027) & (MT)
Table 140. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 141. Global Influenza Drugs and Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 142. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 143. Global Influenza Drugs and Vaccines Sales Forecast by Region (2022-2027) & (MT)
Table 144. Global Influenza Drugs and Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 145. Global Influenza Drugs and Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 146. Global Influenza Drugs and Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Influenza Drugs and Vaccines
Figure 2. Global Influenza Drugs and Vaccines Market Share by Type in 2020 & 2027
Figure 3. Influenza Drugs Product Picture
Figure 4. Influenza Vaccines Product Picture
Figure 5. Global Influenza Drugs and Vaccines Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Global Influenza Drugs and Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Influenza Drugs and Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Influenza Drugs and Vaccines Sales 2016-2027 (MT)
Figure 12. Global Influenza Drugs and Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Influenza Drugs and Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Influenza Drugs and Vaccines Players: Market Share by Revenue in 2020
Figure 16. Influenza Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Influenza Drugs and Vaccines Sales Market Share by Region (2016-2021)
Figure 18. Global Influenza Drugs and Vaccines Sales Market Share by Region in 2020
Figure 19. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2016-2021)
Figure 20. Global Influenza Drugs and Vaccines Revenue Market Share by Region in 2020
Figure 21. U.S. Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Influenza Drugs and Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Influenza Drugs and Vaccines by Type (2016-2021)
Figure 46. Sales Market Share of Influenza Drugs and Vaccines by Application (2016-2021)
Figure 47. Sales Market Share of Influenza Drugs and Vaccines by Application in 2020
Figure 48. Revenue Share of Influenza Drugs and Vaccines by Application (2016-2021)
Figure 49. Revenue Share of Influenza Drugs and Vaccines by Application in 2020
Figure 50. Manufacturing Cost Structure of Influenza Drugs and Vaccines
Figure 51. Manufacturing Process Analysis of Influenza Drugs and Vaccines
Figure 52. Influenza Drugs and Vaccines Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs